pemetrexed ditrometamina dr. reddy's 1000 mg
betapharm arzneimittel gmbh - germania - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 1000mg - antimetaboliti analogi ai acidului folic
pemetrexed ever pharma 25 mg/ml
ever pharma jena gmbh - germania - pemetrexedum - conc. pt. sol. perf. - 25mg/ml - antimetaboliti analogi ai acidului folic
pemetrexed novamed 100 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 100mg - antimetaboliti analogi ai acidului folic
pemetrexed novamed 500 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500mg - antimetaboliti analogi ai acidului folic
pemetrexed aurobindo 500 mg
apl swift services (malta) ltd - malta - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500 mg - antimetaboliti analogi ai acidului folic
pemetrexed seacross 100 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 100mg - antimetaboliti analogi ai acidului folic
pemetrexed seacross 500 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500mg - antimetaboliti analogi ai acidului folic
pemetrexed viatris 25 mg/ml
synthon hispania, s.l. - spania - pemetrexedum - conc. pt. sol. perf. - 25mg/ml - antimetaboliti analogi ai acidului folic
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agenți antineoplazici - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
haemate p 250 ui fviii 600 ui fvw 250 ui/600 ui pulbere şi solvent pentru soluţie injectabilă/perfuzabilă
csl behring gmbh - factorul viii de coagulare uman/factor von willebrand - pulbere şi solvent pentru soluţie injectabilă/perfuzabilă - 250 ui/600 ui